RxDoctor Payments Data

Christopher Hirose, MD

Orthopaedic Surgery · Boise, IDNPI 1437111267

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (43.1%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Arthrex at 41.8% of the total. Reporting peaked in 2022 at $56,851 and has fallen 86.9% since, to $7,445 in 2025. Among orthopaedic surgery clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$181,778in general payments, 2019–2025

Across 206 payments — averaging $882.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$76K
  • Medshape, Inc.$70K
  • Trilliant Surgical LLC.$31K
  • Steelhead Surgical Inc$2K
  • Stryker$724
  • Exactech, Inc.$248
  • plus $1K from 9 others
$184,946in research payments, 2019–2025

Across 13 payments — averaging $14,227 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arthrex$109K
  • Stryker$76K

What the payments were for

  • Royalty or licence$53,97730%
  • Consulting fees$78,37543%
  • Speaking & faculty fees$28,62416%
  • Travel & lodging$13,5807%
  • Food & beverage$6,0223%
  • Education$1,2001%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$181,778 in reported general payments places this provider in the 95th percentile of 139 orthopaedic surgery providers in Idaho.

See all orthopaedic surgery providers in Idaho

Medicare billing

Part B allowed, 2024
$103,683
Medicare patients
324
Services billed
1,320

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxaprozin21$446
Gabapentin40$419
Celecoxib19$348
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$207
Oxycodone Hcl13$85

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →